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A B S T R A C T
Clinical characteristics of unilateral multicentric breast cancer (UMBC) were explo-
red depending on aggressiveness, survival rate, disease-free period and local recurrence.
The study included 296 women with breast cancer, surgically treated between 1990 and
2001. UMBC was histologically proved in 29 (9.8%) patients. Multicentricity was de-
fined by following criteria: a) tumor with minimum one satellite node in the same or
other quadrant of the breast; b) minimum one cut through the breast without tumor
cells; c) histopathologically, discontinued tumors with intra-ductal invasion. The aver-
age age of patients was 63.4 (range 36–85). There were 9 (31.0%) women with one satel-
lite node, 7 (24.1%) women with two satellite nodes, and 13 (44.8%) women with three or
more satellite nodes. At the operation, axilla was positive in 20 (68.9%) women. Steroid
receptors were highly positive in 12 (41.4%) patients. Primary and secondary tumors
were of the same histological type in 26 (89.6%) patients. Local recurrence was found in
only 3 (10.3%) patients. A five-year period without disease was achieved in 24 (82.7%)
women. Kaplan-Meier analysis showed a significantly higher survival rate at lower tu-
mor stages (I or II) unlike in advanced stages with predominantly N2 grade. The results
of this study showed a slightly lower five-year disease-free period than in the case of pa-
tients with monocentric breast cancer (MOBC). The survival rate was significantly lo-
wer at all advanced stages, especially determined by N2 axilla. Therefore, the conclu-
sion is that multicentricity doesn’t increase the risk of poor prognosis, especially at lower
tumor stages.
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Introduction
Until now literature has presented a
few models of multicentric breast cancer
definition. That blur is sometimes caused
by the term of multifocality, which is im-
portant to distinguish because of a differ-
ent way of development, localization and
spread.
Namely, today the established attitu-
de of pathologists is that multifocality
presents a polytopic growth of malignant
cells within one duct and its branches i.e.
appearance of multiple focuses of the sa-
me tumor in the same duct1.
On the other side, there are some defi-
nitions in literature for identification of
UMBC:
a) gross primary tumor with minimum
one satellite node;
b) histopathologically discontinued tumors
with intra-ductal invasion;
c) minimum one cut between tumor
through normal tissue2;
d) each additionally focus of the tumor in
a different quadrant of primary tumor
or in the same quadrant, but at mini-
mally 2.3 cm distance3;
e) possible clonal proliferation of the soli-
tary cancer4.
Some authors believe that the major-
ity of multicentric tumors actually pres-
ent intraductal polytopical metastases of
the same lesion, which means that they
are multifocal5. Obviously, the key of this
problem is separation of two or more breast
tumors. These attitudes differ, from the
opinion according to which only one pure
histological cut between two tumors is
sufficient, to the one in which tumors
must be localized in different breast qua-
drants.
The inconsistency of the problem defi-
nition is followed by a different incidence
of UMBC which ranges, according to pub-
lications, from 10.3% to 65.0%1–3,6–11. Ac-
cording to AJCC/UICC12 accepted models
of TNM classification, only the largest tu-
mors (indexed) are considered as T in the
multicentric form of breast cancer.
The aim of this study is to offer, based
on our own experience, some answers to
the dilemma of potentially higher aggres-
siveness of multicentric than monocen-
tric breast cancer (MOBC), and a higher
liability of local recurrence and distant
metastases, survival rate etc. which is
due to its clinical, biological and histo-
pathological characteristics.
Materials and Methods
According to the retrospective analy-
sis among totally 296 operated patients
with breast cancer (various stages), 29
(9.8%) multicentric and 14 (4.7%) multi-
focal tumors were found. The group of pa-
tients with multicentric disease was ana-
lyzed, but the group of patients with mul-
tifocal cancer was not taken into account.
The average age of patients was 63.4
(range 36–85).
The aim was to answer the following
question: is the multicentric cancer sig-
nificantly more aggressive than mono-
centric cancer in the control group of 267
patients?
The position of primary (indexed) and
secondary (satellite) tumors was consid-
ered depending on different breast quad-
rants. The number and size of tumor
were also included. It is important to
mention that pathologists lacked the ac-
curate description of the number and size
of satellite tumors in some patients.
Scintimammography by the Tc-99m
was not performed preoperatively, but all
patients had accurate mammographic
and ultrasound findings, which did not
indicate multicentricity in any case. We
performed breast mastectomy with axil-
lar exenteration, without sentinel-node
biopsy, after the histopathological exami-
nation proved multicentricity with free
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margins. The removed breast was later
histologically examined in total according
to the standardized procedure of our pa-
thologist. Following the description of in-
dexed tumor, histologically suspect areas
and quadrant of the breast were exam-
ined. Our criteria of multicentricity were:
minimum one cut through the normal
breast tissue between two or more tu-
mors.
The follow-up was determined by the
period from the time of operation to the
last control examination in our Breast
Center.
The adjuvant therapy by the estab-
lished algorithms was preformed in two
oncological centers: University Clinic for
Tumors, Zagreb, and Clinical Hospital
Osijek, Department of Oncology, and par-
tially in General Hospital in Po`ega. The
survival was evaluated by the Kaplan
-Meier cumulative survival proportion
(Figure 1). Hormonal dependence and hi-
stological grade of tumor according to
Bloom-Richardson were tested at three
levels.
Results
The average follow-up period was 6.5
years (range 0.2–12 years). Primary tu-
mor dimensions were 1.0–6.2 cm, average
1.9 cm; for some secondary tumors there
were no precise descriptions in pathologi-
cal findings.
Satellite nodes were found in the ran-
ge from 1–6; they were localized in the
same quadrant in 16 (55.2%) patients
and in 2 or more quadrants in 13 (44.8%)
patients. There were 9 (31%) women with
one satellite node, 7 (24.1%) women with
two satellite nodes and 13 (44.8%) women
with three or more satellite nodes. There
were 26 (89.6%) patients with identical
histopathological findings of primary and
secondary tumor. The histopathological
type of UMBC is shown in Table 1. The
most common type was invasive ductal
carcinoma (79.3%).
The tumor appeared bilaterally in two
cases. Local recurrence was found in three
(10.3%) patients. A five-year period with-
out disease was achieved in 24 (82.7%)
women. There were 20 (68.9%) women
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Fig. 1. Cumulative proportion of survival (Kaplan-Mayer).
with positive axillar nodes (N1-2) and 9
(31.0%) women without metastasis in
lymph nodes.
A high level of tumor hormonal de-
pendence was noted in 12 (41.4%) oper-
ated patients, out of which most were G2
grade according to Bloom-Richardson. The
analyzed UMBC were mostly (55.2%) at
lower stages; I and IIA (T1-2, N0-1, M0),
but 13 (44.8%) patients had tumors in ad-
vanced stages; IIB, IIIa and IIIB.
The results of the surgical treatment
of UMBC were best presented by the
number of local recurrences in each se-
ries. There were 10% local recurrences in
our sample; all of those patients were
IIIA stage and died within a 5-year fol-
low-up.
Discussion
Literature data of several protocols
present UMBC incidence rate ranging from
10.3% to 65.0%1–3,6–11, which depends on
the definition of multicentricity and on
the surgical sampling method6–11. There
were 9.8% patients with UMBC revealed
in our study.
Although the final detection of multi-
centric cancer is feasible by histopatholo-
gical examination of breast tissue sam-
ple, the possibility of revealing the mul-
ticentricity should help us to identify the
candidates for possible conservative breast
surgery3. Scintimammography Tc-99m is
a powerful additional diagnostic method
besides classical mammography and ul-
trasonography in the detection of that
particular breast cancer type13. Preopera-
tive detection of multicentricity and mul-
tifocality could significantly change the
concept of treatment for several patients.
The definition of distance between pri-
mary node and satellite lesions seems
disputable. According to some studies,
only one cut through normal breast tissue
between two tumors2 could be enough.
According to other protocols, multicentri-
city is defined as »any additional focus in
different breast quadrants or in the same
quadrant, but not less than 2.5 cm dis-
tant from the indexed node«3. There is an
opinion according to which only the le-
sions which present in separated breast
quadrants should be considered as inde-
pendent tumors1.
Our attitude is that multicentric tu-
mor is each one which is physically sepa-
rated from another node by normal breast
tissue, irrespective of their distance.
Our retrospective study was partly
laden by insufficient description of the
satellite nodes in some patients. It is im-
portant that each breast, after proven
multicentricity in tissue sample, later un-
derwent a complete, serial, histopatholo-
gical examination. It means that samples
were taken from all quadrants, which
correspond to long ago established proto-
cols of numerous histopathological insti-
tutes7,11,14,15. Although scintimammogra-
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TABLE 1
HISTOPATHOLOGICAL TYPES OF UMBC
Histopathological type Number of cases Percentage
Invasive ductal carcinoma 23 79.30
Invasive lobular carcinoma 2 6.90
Mixed carcinoma 1 3.45
Mucionous carcinoma 2 6.90
Paget carcinoma 1 3.45
Total 29 100.00
phy was not performed, significant corre-
lation between classical mammography
and ultrasonography with histopatholo-
gical finding of multicentricity (75.8%)
was found.
An approximately equal five-year dis-
ease-free period as in monocentric cancer
was noted. The impact of several vari-
ables of survival was analyzed by Rpart
modules within statistical program R16.
Axillar lymph nodes involvement was the
only variable ruled out by the Rpart.
Thus, patients with N2 stage had a sig-
nificantly worse prognosis. Kaplan-Meier
rate showed a significantly lower survival
rate in the group of patients with ad-
vanced stage cancer. Long rank analysis
was used to show if the likelihood of dif-
ference between groups was accidental,
within the interval from 0 to 1. Thus, the
difference between those two groups most
likely was not accidental.
The results of our study rank us among
authors who did not prove a higher ag-
gressiveness of UMBC bearing on general
survival and recurrence-free period9.
Surely, there are other results. After
dissection of the whole breast, Egan veri-
fied mortality rate of 65% in UMBC pa-
tients versus only 27% mortality rate in
MOBC patients stage II17. During the ob-
served period, we proved a major axillar
lymph nodes invasion by the tumor cells
in UMBC patients (68.9%) versus MOBC
patients (59.9%), which correlates with
some other protocols1,14,18.
Nevertheless, if the status of axillar
lymph nodes is a relevant prognostic fac-
tor in breast cancer, there is an open
question: why the survival rate and dis-
ease-free period in UMBC patients, de-
spite a higher incidence of positive axilla,
in our study (as in other authors) is the
same as in monocentric cancer? Vlastos
supposes that in UMBC groups there pro-
bably exists a synergistic combination of
favorable prognostic factors (increased
estrogen receptors, lower incidence of in-
vasive ductal carcinoma etc.), which was
not proved in our patients. Also, this stu-
dy did not confirm a significant correla-
tion between lobular type of breast cancer
and multicentric incidence. Depending on
free histopathological margins, all pa-
tients underwent modified radical mas-
tectomy (MRM), which was also perfor-
med by the majority of authors, who con-
sider multicentricity a contraindication
for conservative breast surgery19–22.
Conclusion
According to the presented clinical, bi-
ological and histological characteristics of
UMBC in 29 out of 296 patients, the re-
sults of this study have unquestionably
shown that the multicentricity of the
breast cancer in cases of N0-1 tumor sta-
ge does not significantly increase the risk
of poor prognosis and five year disease
-free period.
The cumulative proportion survival
rate according to Kaplan-Meier showed
extremely low survival in patients at ad-
vanced tumor stages.
A correlation between lobular and its
more frequent multicentric presentation
wasn’t proved by this study.
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UNILATERALNI MULTICENTRI^NI RAK DOJKE
S A @ E T A K
Klini~ka obilje`ja unilateralnog muticentri~nog raka dojke (UMBC) su istra`ivana
na skupini kirur{ki lije~enih pacijentica razli~ite dobi, pogotovo u odnosu na agresiv-
nost bolesti, stopu pre`ivljenja, period bez bolesti i lokalne recidive. U studiju je bilo
uklju~eno 296 `ena s rakom dojke koje su bile kirur{ki lije~ene od 1990–2001. UMBC je
histopatolo{ki dijagnosticiran u 29 (9,8%) pacijentica. Multicentri~nost se definira po
sljede}im kriterijima: a) tumor s minimalno jednim satelitskim ~vorom u istom ili raz-
li~itom kvadrantu dojke; b) minimalno jedan rez kroz dojku bez tumorskih stanica; c)
histopatolo{ki diskontinuirani tumori s intraduktalnom invazijom. Prosje~na dob bo-
lesnica je bila 63,4 godine (raspon 36–85). Prosje~no pra}enje je bilo 6,5 godina (raspon
0,2–12). Dimenzije primarnog tumora su bile 1,0–6,2 cm, u prosijeku 1,9 cm. Bilo je 9
(31,0%) `ena s jednim satelitskim ~vorom, 7 (24,1%) s dva satelitska ~vora i 13 (44,8%)
s 3 ili vi{e satelitskih ~vorova. Na operaciji pozitivni limfni ~vorovi u aksili su na|eni u
20 (68,9%) `ena. U 13 (44,8%) `ena satelitski tumori su na|eni u vi{e kvadranata iste
dojke. Steroidni receptori su bili pozitivni u 12 (41,4%) pacijentica. Primarni i sekun-
darni tumori su bili istog histolo{kog tipa u 26 (89,6%) bolesnica. Lokalni recidiv na|en
je u 3 (10,3%) pacijentica. Petogodi{nje pre`ivljenje je postignuto u 24 (82,7%) boles-
nice. Kaplan-Meierovom analizom je pokazano zna~ajno du`e pre`ivljenje u ni`im sta-
dijima tumora (I ili II) za razliku od uznapredovalih stadija s N2 gradusom. Sve su
pacijentice s UMBC lije~ene modificiranom radikalnom mastektomijom. Rezultati ove
studije pokazuju ni`e petogodi{nje pre`ivljenje u bolesnica s UMBC nego onih s MOBC.
Stopa pre`ivljenja je bila zna~ajno ni`a u svim uznapredovalim stadijima, posebno u
onih s N2 stadijem aksile. Zaklju~ak je da multicentri~nost ne pove}ava rizik za lo{u
prognozu, posebice u ni`im stadijima bolesti.
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